Skip to main content
Home
  • News
  • Emmes Global
  • Connect with Us

Search form

  • About
    • Clients
  • People
    • Meet Our Leaders
    • Meet Our Employees
    • Careers
  • Services
    • Clinical Research Services
    • Specialty Services & Products
    • Bioinformatics & IT Solutions
    • Advantage eClinical Suite
  • Projects & Publications
    • Projects
    • Publications
Found 2 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is P and Author is Solomon, S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
V. D. Ramanathan, Kumar, M., Jayashri, M., Sathyamoorthy, P., Narayanan, P. R., Solomon, S., Cox, J., Sayeed, E., Ackland, J., Verlinde, C., Vooijs, D., Loughran, K., Barin, B., Lombardo, A., Gilmour, J., Stevens, G., Kochhar, S., Excler, J., and Fast, P., “A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara (rMVA) Virus Preventive Multigenic HIV Subtype C Vaccine (TBC-M4) in Indian Volunteers”, in Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms, Bangkok, Thailand, 2008.
V. Ramanathan, Kumar, M., Mahalingam, J., Narayanan, P., Solomon, S., Boaz, M., Sayeed, E., Scharton-Kersten, T., Seth-Smith, M., Verlinde, C., Vooijs, D., Barin, B., Lombardo, A., Kochhar, S., Excler, J., and Fast, P., “A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
EMMES Corporation
    • About
      • Clients
    • People
      • Meet Our Leaders
      • Meet Our Employees
      • Careers
    • Services
      • Clinical Research Services
      • Specialty Services & Products
      • Bioinformatics & IT Solutions
      • Advantage eClinical Suite
    • Projects & Publications
      • Projects
      • Publications

  • Careers
  • Cookie Policy
  • FCOI
  • GDPR
  • Privacy Shield Policy
  • Purchasing Terms & Conditions
Copyright © 2019, The Emmes Company, LLC Twitter Linkedin